Opportunity
SAM #IL13586
LLNL Seeks Partners to Commercialize Porous Fluoropolymer Technology
Buyer
Lawrence Livermore National Laboratory (LLNL)
Posted
November 19, 2026
Respond By
December 20, 2026
Identifier
IL13586
NAICS
325211
LLNL is seeking industry partners to help develop and commercialize its porous fluoropolymer technology; this notice is not a procurement opportunity. - Opportunity: Collaboration with Lawrence Livermore National Laboratory (LLNL), operated by Lawrence Livermore National Security, LLC for the U.S. Department of Energy. - Technology: Ultraviolet- or thermally curable fluoropolymer formulations with controlled macro-, meso-, and micro-porosity. Potential manufacturing methods include casting, coating, molding, and additive manufacturing. - Potential applications: Waterproof fabrics, biomedical products, and electrochemical energy-storage components. - Technology status: Technology Readiness Level (TRL) 3; LLNL reports that patent protection has been filed. - Interested organizations: Submit the organization’s name and address, a point of contact’s details, and information about relevant expertise or facilities for commercialization. - Procurement details: No purchase, contract value, quantity, performance period, or specific vendor is identified.
Description
Opportunity:
Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract no. DE-AC52-07NA27344 (Contract 44) with the U.S. Department of Energy (DOE), is offering the opportunity to enter into a collaboration to further develop and commercialize its thermally curable, porous fluoropolymer formulations for advanced manufacturing.
Background:
Fluoropolymers are commercially important materials known for their nonstick, low-friction surfaces. They also offer excellent chemical resistance, strong mechanical properties, high-temperature performance, and dielectric strength. The two primary commercial porous fluoropolymers are expanded polytetrafluoroethylene (ePTFE) and sintered polytetrafluoroethylene (sPTFE), which differ primarily in their microscale structures.
Both ePTFE and sPTFE are difficult to process and require specialized equipment. As a result, they are generally limited to relatively simple geometries, such as cylindrical or planar forms.
Fluoropolymers containing substantial air-filled voids form microporous structures that enable gas transport and can increase dielectric strength relative to bulk, nonporous materials. At the same time, the fluoropolymer matrix, particularly in commonly used ePTFE, retains its ability to repel liquids and water.
Description:
LLNL researchers have developed porous fluoropolymer formulations that can be patterned into arbitrary three-dimensional structures using casting, conformal coating, molding, and additive manufacturing. The formulations may be thermoplastic or thermosetting and can be cured using external stimuli, including thermal or photochemical processes.
These formulations incorporate a sacrificial material, or porogen, that generates nanoscale to microscale porosity in the cured fluoropolymer. Porogens may be added before curing or formed during curing through intrinsic chemical reactions. They are removed during or after curing, leaving a nanoporous or microporous structure within the fluoropolymer matrix.
Both unfilled and porogen-containing fluoropolymer feedstocks can be processed using 3D-printing techniques. For a given porogen, the morphology and geometry of the resulting pores can be controlled by adjusting the curing conditions and the porogen-to-fluoropolymer ratio.
Advantages/Benefits:
Multiscale porous structures: Enables the creation and control of three-dimensional porous fluoropolymers at multiple length scales using thermally or photochemically curable thermosetting resins. Tailored material properties: Provides greater control over component geometry, pore structure, and resulting material properties through formulation chemistry and manufacturing processes. Simplified, flexible manufacturing: Expands the design space while simplifying fabrication by enabling casting, coating, molding, and 3D printing of porous fluoropolymers.
Potential Applications:
Wearable fabrics/waterproofing. Biomedical applications, including patches, lipoatrophy implants, sutures, lead assemblies, stents and dental floss. Gas diffusion layers in many electrochemical energy storage.
Development Status:
Current stage of technology development: TRL3
LLNL has filed for patent protection on this invention.
U.S. Patent Application No. 20220064427 Actinic And Thermal Cure Fluoropolymers With Controlled Porosity published 3/3/2022
LLNL is seeking industry partners with a demonstrated ability to bring such inventions to the market. Moving critical technology beyond the Laboratory to the commercial world helps our licensees gain a competitive edge in the marketplace. All licensing activities are conducted under policies relating to the strict nondisclosure of company proprietary information.
Please visit the IPO website at https://ipo.llnl.gov/resources for more information on working with LLNL and the industrial partnering and technology transfer process.
Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing LLNL's Ultraviolet or Thermally Curable Fluoropolymers Formulations with Controlled Macro-, Meso- and Micro-Porosity should provide an electronic OR written statement of interest, which includes the following:
Company Name and address. The name, address, and telephone number of a point of contact. A description of corporate expertise and/or facilities relevant to commercializing this technology.
Please provide a complete electronic OR written statement to ensure consideration of your interest in LLNL's Ultraviolet or Thermally Curable Fluoropolymers Formulations with Controlled Macro-, Meso- and Micro-Porosity.
The subject heading in an email response should include the Notice ID and/or the title of LLNL’s Technology/Business Opportunity and directed to the Primary and Secondary Point of Contacts listed below.
Written responses should be directed to:
Lawrence Livermore National Laboratory
Innovation and Partnerships Office
P.O. Box 808, L-779
Livermore, CA 94551-0808
Attention: IL13586